MEDA to Acquires Acton Pharmaceuticals
Meda will acquire Acton Pharmaceuticals.
The specialty pharmaceutical company, Meda has agreed to acquire Acton Pharmaceuticals, a specialty respiratory company. Acton’s lead product is Aerospan. Aerospan is an inhaler for the treatment of asthma that contains the active substance flunisolide.
The launch of Aerospan is expected to begin in 2014 for $135 million plus $10 million in a contingent, near-term development milestone. Acton will also receive certain sales-based milestones, which may bring the total potential acquisition value of up to $200 million.
Source: Meda
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
